Skip to main content

BMY - Bristol-Myers Squibb Co

This page shows which of the focused investors we track hold BMY and how their positions changed, so you can see how much conviction the group has in the stock.

In Q4 2019 it was held by 11 managers with an aggregate reported value of $3.78B, which is 0.40% of the combined portfolio.

As of Q4 2019, 11 tracked institutional managers held BMY (Bristol-Myers Squibb Co) with an aggregate reported value of $3.78B — 0.40% of the combined AlphaBaseline portfolio.

Get email alerts when a tracked manager trades BMY — sign in or create a free account.

Source
Curated SEC 13F filings
Period
Q4 2019
Ticker
BMY

13F data is delayed and excludes shorts/non-13F assets.

Holders

1Dodge & Cox - Dodge & Cox2.47%Reduce -0.4%50,268,777$3.23B
2Seth Klarman - Baupost Group 2.84%Reduce -60.0%4,000,000$256.76M
3Richard Pzena - Pzena Investment Management0.76%Reduce -1.6%2,537,875$162.91M
4Kahn Brothers Group - Kahn Brothers Group8.20%Reduce -1.8%1,053,732$67.64M
5David Rolfe - Wedgewood Partners2.55%New391,442$25.13M
6Mairs & Power Growth Fund - Mairs & Power Growth Fund0.16%Reduce -2.9%222,457$14.28M
7Muhlenkamp - Muhlenkamp3.46%New123,223$7.91M
8Lee Ainslie - Maverick Capital0.11%Reduce -7.4%115,253$7.4M
9Hillman Value Fund - Hillman Value Fund3.94%New86,641$5.56M
10Jensen Investment Management - Jensen Investment Management0.02%Add +4.5%27,175$1.74M
11David Katz - Matrix Asset Advisors0.12%Reduce -4.9%11,700$751K
Loading holder history for BMY…